Advanced Cell Will Test Stem-Cell Therapy for Vision
This article is for subscribers only.
Advanced Cell Technology Inc. said it was cleared by U.S. regulators to test a therapy made from embryonic stem cells in patients with macular degeneration, a leading cause of vision loss.
Doctors will inject retinal cells made from stem cells into the eyes of 12 people with the so-called dry form of macular degeneration, said Gary Rabin, interim chairman and chief executive officer of the Marlboro, Massachusetts-based company. The disease affects about 15 million Americans and new therapies may generate as much as $30 billion in sales, Rabin said.